Helena Edlund

Helena Edlund (born 1960) is a Swedish professor and molecular biologist. She received her Ph.D. from Umeå University in 1991.[1] She is a professor in Molecular Developmental Biology at Umeå University where she researches Type 2 diabetes and β-cell function.[2] She is one of the founders, along with Thomas Edlund and Olof Karlsson, of the biopharmaceutical company Betagenon.[3]

Helena Edlund
NationalitySwedish
Other namesHelena Ohlsson
EducationUmeå Universitet
OccupationDiabetes researcher

In 2000, Edlund was the recipient of the Minkowski Prize given by the European Association for the Study of Diabetes (EASD) for her work in factors controlling beta-cell identity and glucose homeostasis.[4] She is a member of the Royal Swedish Academy of Sciences. She has written numerous articles on beta cell differentiation, beta cell function, pancreatic development, and Type 2 diabetes .[1]

References
  1. "Helena Edlund". ORCID. Retrieved 4 November 2021.
  2. "Grp Helena Edlund". Umeå University. Retrieved 4 November 2021.
  3. "Management". Betagenon. Retrieved 4 November 2021.
  4. "Minkowski". EASD. Retrieved 4 November 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.